Stock Market Today: Crude's $40 Move, MU Price Target Hikes, NVO/HIMS Deal #shorts
•March 9, 2026
0
Why It Matters
Geopolitical turbulence and sector‑specific catalysts are driving sharp price swings, highlighting the need for investors to track oil developments, DRAM demand, and biotech collaborations closely.
Key Takeaways
- •Nasdaq and Russell close over 1% after early dip.
- •Crude oil swings $40, ending near $86 after Trump comment.
- •Micron gains >5% on price target hikes to $525 and $430.
- •Data‑center DRAM demand drives Micron’s valuation boost significantly.
- •Hims & Hers jumps >40% after Novo Nordisk GLP‑1 partnership.
Summary
The market recap highlighted a volatile day where U.S. equities rebounded after an early dip, with the Nasdaq and Russell 2000 each gaining more than 1% and the S&P 500 adding roughly 0.8%.
Crude oil prices swung nearly $40, spiking above $120 on production cuts before settling near $86 after President Trump signaled the Iran conflict was nearing resolution. Meanwhile, Micron Technology surged over 5% after Saskatchewan and Citi lifted its price targets to $525 and $430, respectively, citing stronger DRAM pricing and data‑center demand. Hims & Hers saw a 40% jump on news of a partnership with Novo Nordisk to bring GLP‑1 therapies to its tele‑health platform.
The analysts’ revisions reflected a $180 increase in Micron’s valuation ceiling, while the oil rally was driven by geopolitical headlines and a Trump comment that the U.S. expects a four‑to‑five‑week timeline for the Iran war. Novo Nordisk’s involvement adds OMIC and WGOI products to Hims & Hers’ pipeline, boosting investor sentiment.
These moves underscore how geopolitical shocks, sector‑specific demand cycles, and strategic biotech alliances can quickly reshape market sentiment, suggesting investors should monitor oil‑related news, DRAM supply dynamics, and emerging health‑tech partnerships for future volatility.
Original Description
Crude oil made a near-$40 move from the overnight hours to Monday's closing bell. Sam Vadas explains how unraveling headline risks are affecting price action. On stock moves, she discusses the potential partnership between Novo Nordisk (NVO) and Hims & Hers (HIMS) paired with price target hikes in Micron (MU).
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe
Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185
Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7
Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore
Watch on DistroTV - https://www.distro.tv/live/schwab-network/
Follow us on X – https://twitter.com/schwabnetwork
Follow us on Facebook – https://www.facebook.com/schwabnetwork
Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/
About Schwab Network - https://schwabnetwork.com/about
#novonordisk #novo #crudeoil #micron #mu #hims #healthcare #economy #stockmarket #stocks #finance
0
Comments
Want to join the conversation?
Loading comments...